FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 83 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,603 | -49.7% | 361 | -62.6% | 0.00% | – |
| Q2 2023 | $3,185 | -88.6% | 965 | -90.1% | 0.00% | – |
| Q1 2023 | $27,834 | +19.7% | 9,766 | +205.7% | 0.00% | – |
| Q4 2022 | $23,260 | -48.3% | 3,195 | -42.5% | 0.00% | – |
| Q3 2022 | $45,000 | +55.2% | 5,553 | -5.4% | 0.00% | – |
| Q2 2022 | $29,000 | -91.3% | 5,870 | -58.2% | 0.00% | – |
| Q1 2022 | $332,000 | -17.6% | 14,053 | -38.4% | 0.00% | – |
| Q4 2021 | $403,000 | +144.2% | 22,818 | +289.5% | 0.00% | – |
| Q3 2021 | $165,000 | +98.8% | 5,859 | -26.1% | 0.00% | – |
| Q2 2021 | $83,000 | -24.5% | 7,932 | -15.2% | 0.00% | – |
| Q1 2021 | $110,000 | -50.2% | 9,349 | -50.4% | 0.00% | – |
| Q4 2020 | $221,000 | +88.9% | 18,832 | +26.9% | 0.00% | – |
| Q3 2020 | $117,000 | -58.1% | 14,840 | -3.0% | 0.00% | – |
| Q2 2020 | $279,000 | +156.0% | 15,298 | +67.7% | 0.00% | – |
| Q1 2020 | $109,000 | +230.3% | 9,122 | +357.7% | 0.00% | – |
| Q4 2019 | $33,000 | +1550.0% | 1,993 | +447.5% | 0.00% | – |
| Q3 2019 | $2,000 | – | 364 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
| COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
| RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
| RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
| Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
| Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
| Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
| DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |